Search Results - "Journal of Neural Transmission"

Refine Results
  1. 1

    Epidemiology of Parkinson’s disease by Tysnes, Ole-Bjørn, Storstein, Anette

    Published in Journal of Neural Transmission (01-08-2017)
    “…Parkinson’s disease (PD) affects 1–2 per 1000 of the population at any time. PD prevalence is increasing with age and PD affects 1% of the population above…”
    Get full text
    Journal Article
  2. 2

    Animal models of major depression: drawbacks and challenges by Planchez, Barbara, Surget, Alexandre, Belzung, Catherine

    Published in Journal of Neural Transmission (01-11-2019)
    “…Major depression is a leading contributor to the global burden of disease. This situation is mainly related to the chronicity and/or recurrence of the…”
    Get full text
    Journal Article
  3. 3

    Challenges of neuropathic pain: focus on diabetic neuropathy by Rosenberger, Daniela C., Blechschmidt, Vivian, Timmerman, Hans, Wolff, André, Treede, Rolf-Detlef

    Published in Journal of Neural Transmission (01-04-2020)
    “…Neuropathic pain is a frequent condition caused by a lesion or disease of the central or peripheral somatosensory nervous system. A frequent cause of…”
    Get full text
    Journal Article
  4. 4

    Glutamate as a neurotransmitter in the healthy brain by Zhou, Y., Danbolt, N. C.

    Published in Journal of Neural Transmission (01-08-2014)
    “…Glutamate is the most abundant free amino acid in the brain and is at the crossroad between multiple metabolic pathways. Considering this, it was a surprise to…”
    Get full text
    Journal Article
  5. 5

    Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship by Herrero Babiloni, Alberto, De Koninck, Beatrice P., Beetz, Gabrielle, De Beaumont, Louis, Martel, Marc O., Lavigne, Gilles J.

    Published in Journal of Neural Transmission (01-04-2020)
    “…Sleep disturbances and chronic pain are considered public health concerns. They are frequently associated, and the direction of its relationship and possible…”
    Get full text
    Journal Article
  6. 6

    Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies by Jellinger, Kurt A.

    Published in Journal of Neural Transmission (01-04-2018)
    “…Dementia with Lewy bodies (DLB) and Parkinson’s disease-dementia (PDD), although sharing many clinical, neurochemical and morphological features, according to…”
    Get full text
    Journal Article
  7. 7

    The IL-1β phenomena in neuroinflammatory diseases by Mendiola, Andrew S., Cardona, Astrid E.

    Published in Journal of Neural Transmission (01-05-2018)
    “…It is becoming increasingly clear that neuroinflammation has a causal role in the pathogenesis of central nervous system (CNS)-related diseases, and therefore…”
    Get full text
    Journal Article
  8. 8

    Magnetic resonance imaging for the diagnosis of Parkinson’s disease by Heim, Beatrice, Krismer, Florian, De Marzi, Roberto, Seppi, Klaus

    Published in Journal of Neural Transmission (01-08-2017)
    “…The differential diagnosis of parkinsonian syndromes is considered one of the most challenging in neurology and error rates in the clinical diagnosis can be…”
    Get full text
    Journal Article
  9. 9

    Parkinson’s: a syndrome rather than a disease? by Titova, Nataliya, Padmakumar, C., Lewis, Simon J. G., Chaudhuri, K. Ray

    Published in Journal of Neural Transmission (01-08-2017)
    “…Emerging concepts suggest that a multitude of pathology ranging from misfolding of alpha-synuclein to neuroinflammation, mitochondrial dysfunction, and…”
    Get full text
    Journal Article
  10. 10

    Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer by Tanaka, Masaru, Spekker, Eleonóra, Szabó, Ágnes, Polyák, Helga, Vécsei, László

    Published in Journal of Neural Transmission (01-06-2022)
    “…Following introduction of the monoamine oxidase type B inhibitor selegiline for the treatment of Parkinson’s disease (PD), discovery of the action mechanism of…”
    Get full text
    Journal Article
  11. 11

    Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation by Brabenec, L., Mekyska, J., Galaz, Z., Rektorova, Irena

    Published in Journal of Neural Transmission (01-03-2017)
    “…Hypokinetic dysarthria (HD) occurs in 90% of Parkinson’s disease (PD) patients. It manifests specifically in the areas of articulation, phonation, prosody,…”
    Get full text
    Journal Article
  12. 12

    Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis by Devos, David, Cabantchik, Z. Ioav, Moreau, Caroline, Danel, Véronique, Mahoney-Sanchez, Laura, Bouchaoui, Hind, Gouel, Flore, Rolland, Anne-Sophie, Duce, James A., Devedjian, Jean-Christophe

    Published in Journal of Neural Transmission (01-02-2020)
    “…Focal iron accumulation associated with brain iron dyshomeostasis is a pathological hallmark of various neurodegenerative diseases (NDD). The application of…”
    Get full text
    Journal Article
  13. 13

    Human tyrosine hydroxylase in Parkinson’s disease and in related disorders by Nagatsu, Toshiharu, Nakashima, Akira, Ichinose, Hiroshi, Kobayashi, Kazuto

    Published in Journal of Neural Transmission (01-04-2019)
    “…Parkinson’s disease (PD) is an aging-related movement disorder mainly caused by a deficiency of neurotransmitter dopamine (DA) in the striatum of the brain and…”
    Get full text
    Journal Article
  14. 14

    Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators by Messlinger, Karl, Balcziak, Louis K., Russo, Andrew F.

    Published in Journal of Neural Transmission (01-04-2020)
    “…The trigeminal ganglion with its three trigeminal nerve tracts consists mainly of clusters of sensory neurons with their peripheral and central processes. Most…”
    Get full text
    Journal Article
  15. 15

    The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion plus varenicline in rats by Olsson, Yasmin, Lidö Höifödt, Helga, Ademar, Karin, Cadeddu, Davide, Ericson, Mia, Söderpalm, Bo

    Published in Journal of Neural Transmission (2024)
    “…Alcohol Use Disorder (AUD) is a relapsing brain disorder that involves perturbations of brain dopamine (DA) systems, and combined treatment with varenicline +…”
    Get full text
    Journal Article
  16. 16

    Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies by Kaar, Stephen J., Angelescu, Ilinca, Marques, Tiago Reis, Howes, Oliver D.

    Published in Journal of Neural Transmission (01-12-2019)
    “…Parvalbumin interneurons are fast-spiking GABAergic neurons that provide inhibitory control of cortical and subcortical circuits and are thought to be a key…”
    Get full text
    Journal Article
  17. 17

    Parkinson’s disease and iron by Mochizuki, Hideki, Choong, Chi-Jing, Baba, Kousuke

    Published in Journal of Neural Transmission (01-02-2020)
    “…While the initial causes of Parkinson’s disease (PD) are not clearly defined, iron deposition has long been implicated in the pathogenesis of PD. The…”
    Get full text
    Journal Article
  18. 18

    Recent update on the heterogeneity of the Alzheimer’s disease spectrum by Jellinger, Kurt A.

    Published in Journal of Neural Transmission (2022)
    “…Alzheimer’s disease (AD), the most common form of dementia worldwide, is a mixed proteinopathy (β-amyloid, tau and other proteins). Classically defined as a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Amyloid β oligomers (AβOs) in Alzheimer’s disease by Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr

    Published in Journal of Neural Transmission (01-02-2018)
    “…The causative role of amyloid β 1–42 (Aβ42) aggregation in the pathogenesis of Alzheimer’s disease (AD) has been under debate for over 25 years. Primarily,…”
    Get full text
    Journal Article